MMP9 and lung carcinoma: Aptamers targeting A549 lung cancer cells, ASOs targeting c-raf-1 mRNA (a cancer-associated biomarker) and DNAzymes targeting lung-cancer-proliferation-associated matrix metalloproteinase-9 could be hybridized to the DNA framework in a site-specific manner.